Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kimberly M Thompson

Showing results (1-10 of 180) with videos related to

Pageof 18
Sort By:
Child and Adolescent Psychiatric Clinics of North America|June 7, 2005
Addicted media: substances on screenKimberly M Thompson
Vaccines|November 26, 2024
The Health and Economic Benefits of United States Investments in Measles and Rubella Control and EliminationKimberly M Thompson
Risk Analysis : an Official Publication of the Society for Risk Analysis|April 5, 2013
Modeling poliovirus risks and the legacy of polio eradicationKimberly M Thompson
Lancet (London, England)|July 15, 2014
Polio endgame management: focusing on performance with or without inactivated poliovirus vaccineKimberly M Thompson
Risk Analysis : an Official Publication of the Society for Risk Analysis|June 10, 2016
Evolution and Use of Dynamic Transmission Models for Measles and Rubella Risk and Policy AnalysisKimberly M Thompson
The Lancet. Infectious Diseases|August 21, 2015
Good news for billions of children who will receive IPVKimberly M Thompson
The Lancet. Global Health|March 14, 2024
Excess vaccine-preventable disease mortality due to COVID-19Kimberly M Thompson
Risk Analysis : an Official Publication of the Society for Risk Analysis|June 29, 2002
Variability and uncertainty meet risk management and risk communicationKimberly M Thompson
The Lancet. Microbe|May 3, 2025
Comparing mucosal immunity induced by type 2 oral poliovirus vaccinesKimberly M Thompson
Medgenmed : Medscape General Medicine|November 3, 2004
Changes in children's exposure as a function of age and the relevance of age definitions for exposure and health risk assessmentKimberly M Thompson
Pageof 18

Showing results (1-10 of 180) with videos related to

Sort By:
Pageof 18
Child and Adolescent Psychiatric Clinics of North America|June 7, 2005
Addicted media: substances on screenKimberly M Thompson
Vaccines|November 26, 2024
The Health and Economic Benefits of United States Investments in Measles and Rubella Control and EliminationKimberly M Thompson
Risk Analysis : an Official Publication of the Society for Risk Analysis|April 5, 2013
Modeling poliovirus risks and the legacy of polio eradicationKimberly M Thompson
Lancet (London, England)|July 15, 2014
Polio endgame management: focusing on performance with or without inactivated poliovirus vaccineKimberly M Thompson
Risk Analysis : an Official Publication of the Society for Risk Analysis|June 10, 2016
Evolution and Use of Dynamic Transmission Models for Measles and Rubella Risk and Policy AnalysisKimberly M Thompson
The Lancet. Infectious Diseases|August 21, 2015
Good news for billions of children who will receive IPVKimberly M Thompson
The Lancet. Global Health|March 14, 2024
Excess vaccine-preventable disease mortality due to COVID-19Kimberly M Thompson
Risk Analysis : an Official Publication of the Society for Risk Analysis|June 29, 2002
Variability and uncertainty meet risk management and risk communicationKimberly M Thompson
The Lancet. Microbe|May 3, 2025
Comparing mucosal immunity induced by type 2 oral poliovirus vaccinesKimberly M Thompson
Medgenmed : Medscape General Medicine|November 3, 2004
Changes in children's exposure as a function of age and the relevance of age definitions for exposure and health risk assessmentKimberly M Thompson
Pageof 18